LogoThe CIFAR Logo, without the subtextLogoA logo in a stroked circle shapeReach LogoThe Reach Magazine Logo MarkNews & Ideas LogoThe News & Ideas logoSearch IconA logo in a stroked circle shapeMenu IconA hamburger icon for use with navigational elementsComment Bubble IconA simple bubble icon used to represent commentsTwitter IconThe Twitter logo, for use in social buttonsFacebook IconThe Facebook logo, for use in social buttonsYouTube IconThe YouTube logo, for use in social buttonsLinkedIn IconThe LinkedIn logo, for use in social buttonsEmail IconAn envelope icon for

CIFAR Search

Main navigation

Frederick P. Roth

Frederick (Fritz) Roth’s research team is developing technology to accelerate discovery of gene functions, the pathways they encode, the relationships of genes and pathways and variation to human disease. They are exploring new ways to adapt technology for sequencing DNA to increase the scale at which we can determine a gene’s function. For example, they are harnessing sequencing technology to systematically map the effects of multiple genetic changes in combination across multiple environments. They are applying advanced sequencing technologies to efficiently measure interactions between proteins, and to identify the effects of viral proteins or cancer-causing signaling proteins on the network of interactions between human proteins.

A current major challenge in medicine is interpreting the disease risk of variants in individual human genomes. Roth’s team has recently undertaken an effort to test the functional effect of essentially all possible variants in human disease genes, so that the impact of even the rarest human sequence variants can be interpreted as soon as they are first detected. Roth’s team continues to focus on developing technology to more efficiently relate genes to the functioning of living systems and human disease.

Awards

Canada Excellence Research Chair, 2011.

National Science Foundation Graduate Fellowship, 1993-1996.

Member of the US National Institutes of Health Study Section on Genomics, Computational Biology and Technology